Literature DB >> 20972691

Pathogenicity and virulence of the present hantaviruses in Bosnia and Herzegovina: the impact on renal function.

M Hukić1, A Valjevac, D Tulumovic, F Numanovic, P Heyman.   

Abstract

Dobrava (DOBV) and Puumala (PUUV) viruses are endemic throughout the Balkans and cause haemorrhagic fever with renal syndrome (HFRS). The aim of this study was to assess the impact of two different hantaviruses on renal function in HFRS patients during the acute stage of illness. We also aimed to assess the DOBV and PUUV distribution between symptomatic HFRS patients and asymptomatic hantavirus antibody-positive subjects. The study included 264 symptomatic HFRS patients and 63 asymptomatic hantavirus antibody-positive healthy subjects. In our study, 131 (49.6%) HFRS patients were regarded as PUUV- and 69 (26.1%) as DOBV-infected patients, while in 64 (24.2%) of HFRS patients that showed all clinical and biochemical signs of HFRS, the causal hantavirus could not be determined with commercially available tests. DOBV-infected patients were associated with more requirements for haemodialysis treatment, lower diuresis and higher serum creatinine and urea values compared to PUUV-infected patients. PUUV was significantly predominant in asymptomatic hantavirus antibody-positive subjects (69.8%) compared to HFRS patients. DOBV was present in 17.5% of asymptomatic subjects and, interestingly, the preferential hantavirus serotype could not be determined in 12.7% of the asymptomatic antibody-positive subjects.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20972691     DOI: 10.1007/s10096-010-1097-6

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  17 in total

1.  Haemorrhagic fever with renal syndrome in Croatia.

Authors:  M Miletić Medved; A Markotić; L Cebalo; B Turković; T Avsic Zupanc
Journal:  Lancet       Date:  2002-08-03       Impact factor: 79.321

2.  Comparison of the effects of Puumala and Dobrava viruses on early and long-term renal outcomes in patients with haemorrhagic fever with renal syndrome.

Authors:  Denijal Tulumovic; Goran Imamovic; Enisa Mesic; Mirsada Hukic; Ajsa Tulumovic; Alma Imamovic; Enver Zerem
Journal:  Nephrology (Carlton)       Date:  2010-04       Impact factor: 2.506

Review 3.  Hantaviruses are likely threat to NATO forces in Bosnia and Herzegovina and Croatia.

Authors:  A Markotić; J W LeDuc; D Hlaca; S Rabatić; A Sarcević; G Dasić; A Gagro; I Kuzman; V Barac; T Avsic-Zupanc; I Beus; D Dekaris
Journal:  Nat Med       Date:  1996-03       Impact factor: 53.440

4.  Haemorrhagic fever with renal syndrome in north-east Bosnia.

Authors:  M Hukic; A Kurt; S Torstensson; A Lundkvist; D Wiger; B Niklasson
Journal:  Lancet       Date:  1996-01-06       Impact factor: 79.321

5.  Characteristics of Puumala and Dobrava infections in Croatia.

Authors:  A Markotić; S T Nichol; I Kuzman; A J Sanchez; T G Ksiazek; A Gagro; S Rabatić; R Zgorelec; T Avsic-Zupanc; I Beus; D Dekaris
Journal:  J Med Virol       Date:  2002-04       Impact factor: 2.327

Review 6.  Hantavirus infection: a review and global update.

Authors:  Zhenqiang Bi; Pierre B H Formenty; Cathy E Roth
Journal:  J Infect Dev Ctries       Date:  2008-02-01       Impact factor: 0.968

7.  [Puumala and Dobrava viruses in the northeastern and central regions of Bosnia].

Authors:  Mirsad Hukić; Sefkija Muzaferović; Denijal Tulumović; Lejla Calkić; Sana Sabović; Sead Karakas; Damir Sabitović; Goran Pavić; Enis Osmancević
Journal:  Acta Med Croatica       Date:  2003

8.  Hemorrhagic fever with renal syndrome in Yugoslavia: epidemiologic and epizootiologic features of a nationwide outbreak in 1989.

Authors:  A Gligic; R Stojanovic; M Obradovic; D Hlaca; N Dimkovic; G Diglisic; V Lukac; Z Ler; R Bogdanovic; B Antonijevic
Journal:  Eur J Epidemiol       Date:  1992-11       Impact factor: 8.082

Review 9.  Hantaviruses. a short review.

Authors:  John A Lednicky
Journal:  Arch Pathol Lab Med       Date:  2003-01       Impact factor: 5.534

Review 10.  Hantavirus infections in Europe.

Authors:  Olli Vapalahti; Jukka Mustonen; Ake Lundkvist; Heikki Henttonen; Alexander Plyusnin; Antti Vaheri
Journal:  Lancet Infect Dis       Date:  2003-10       Impact factor: 25.071

View more
  5 in total

1.  Clinical aspects of hantavirus infections in Bulgaria.

Authors:  I Christova; M Pishmisheva; I Trifonova; N Vatev; M Stoycheva; M Tiholova; D Igova; M Baev; R Karagyaurova; U Prokopova
Journal:  Wien Klin Wochenschr       Date:  2017-02-22       Impact factor: 1.704

Review 2.  The kidney in hantavirus infection-epidemiology, virology, pathophysiology, clinical presentation, diagnosis and management.

Authors:  Felix C Koehler; Veronica Di Cristanziano; Martin R Späth; K Johanna R Hoyer-Allo; Manuel Wanken; Roman-Ulrich Müller; Volker Burst
Journal:  Clin Kidney J       Date:  2022-01-29

3.  Construction of a Seasonal Difference-Geographically and Temporally Weighted Regression (SD-GTWR) Model and Comparative Analysis with GWR-Based Models for Hemorrhagic Fever with Renal Syndrome (HFRS) in Hubei Province (China).

Authors:  Liang Ge; Youlin Zhao; Zhongjie Sheng; Ning Wang; Kui Zhou; Xiangming Mu; Liqiang Guo; Teng Wang; Zhanqiu Yang; Xixiang Huo
Journal:  Int J Environ Res Public Health       Date:  2016-10-29       Impact factor: 3.390

4.  Clinical characterization of two severe cases of hemorrhagic fever with renal syndrome (HFRS) caused by hantaviruses Puumala and Dobrava-Belgrade genotype Sochi.

Authors:  Ellen Krautkrämer; Christian Nusshag; Alexandra Baumann; Julia Schäfer; Jörg Hofmann; Paul Schnitzler; Boris Klempa; Peter T Witkowski; Detlev H Krüger; Martin Zeier
Journal:  BMC Infect Dis       Date:  2016-11-14       Impact factor: 3.090

Review 5.  Hanta hemorrhagic fever with renal syndrome: A pathology in whose diagnosis kidney biopsy plays a major role (Review).

Authors:  Gabriela Lupuşoru; Mircea Lupuşoru; Ioana Ailincăi; Lavinia Bernea; Andreea Berechet; Radu Spătaru; Gener Ismail
Journal:  Exp Ther Med       Date:  2021-07-12       Impact factor: 2.447

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.